This is an actively recruiting Phase 3 trial with no results posted; the registry record describes planned design and endpoints only.
Reported
Planned enrollment372
Study phasePHASE 3
Treatment duration52 weeks
Clinical trial
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is an actively recruiting Phase 3 trial with no results posted; the registry record describes planned design and endpoints only.